Literature DB >> 8675226

HLA-DQ3 is associated with Graves' disease in African-Americans.

M H Ofosu1, G Dunston, L Henry, D Ware, W Cheatham, A Brembridge, C Brown, L Alarif.   

Abstract

HLA heterogeneity occurs in various ethnic groups and has been significantly associated with Graves' disease. In this study we have determined that DQ3 is associated with Graves' disease in African-Americans. Human leukocyte antigen (HLA) typing of D-region antigens in 139 controls and 45 Graves' disease patients reveals significant differences for HLA-DR2, DR9, DQ1, and DQ3. The latter remained significant after correction. Increases in HLA-DR9 and DR3 are associated with increases in DQ3 and DQ2, respectively. The decrease in DR2 is associated with a decrease in DQ1. The associated increases and decreases in DR with DQ antigens probably reflect linkage disequilibrium. Patients were evaluated for autoantibodies against microsomal antigens and/or against thyroglobulin. All of the normal control volunteers were negative for thyroid antibodies and thirteen percent of patients produced autoantibodies. No significant associations were detected for antibody production, type of treatment required, age of onset, family history of Graves', status of T3, T4 levels, goiter and/or ophthalmopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675226     DOI: 10.3109/08820139609059294

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  5 in total

Review 1.  Role of genetic and non-genetic factors in the etiology of Graves' disease.

Authors:  M Marinò; F Latrofa; F Menconi; L Chiovato; P Vitti
Journal:  J Endocrinol Invest       Date:  2014-11-25       Impact factor: 4.256

2.  Genetics of autoimmune thyroid disease in the Lebanese population.

Authors:  C Farra; J Awwad; A Fadlallah; G Sebaly; G Hage; M Souaid; H Ashkar; R Medlej; M H Gannageh; G Halaby
Journal:  J Community Genet       Date:  2012-03-06

3.  Autoimmune thyroid disease elicited by NY-ESO-1 vaccination.

Authors:  Roberto Vita; Fabrizio Guarneri; Ravin Agah; Salvatore Benvenga
Journal:  Thyroid       Date:  2013-07-25       Impact factor: 6.568

4.  The genetic basis of graves' disease.

Authors:  Rafał Płoski; Konrad Szymański; Tomasz Bednarczuk
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

5.  Thyroid Dysfunction in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors (ICIs): Outcomes in a Multiethnic Urban Cohort.

Authors:  Angelica D'Aiello; Juan Lin; Rasim Gucalp; Vafa Tabatabaie; Haiying Cheng; Noah A Bloomgarden; Yaron Tomer; Balazs Halmos
Journal:  Cancers (Basel)       Date:  2021-03-23       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.